Back to companies
NEUROCRINE BIOSCIENCES INC
NBIXUSNASDAQPharmaceuticals & HealthcareNEUROCRINE BIOSCIENCES INC
Revenue
$2.9bn
YoY +21.4%
Operating income
$619.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API